Net earnings per share (EPS TTM): Apogee Pharma (APGE)

Graphic logo of apogeetherapeutics.com (APGE)

The fundamental net income per share TTM metric on the GURU.Markets chart demonstrates yield dynamics, where the -4.33 level represents the current value. Apogee Therapeutics (APGE) focuses on developing biologics with infrequent injection intervals for skin therapy. Its status as a scientific pioneer in dermatitis treatment strengthens shareholder confidence, while operational activities rely on strict oversight of external research contractors.

APGE Apogee Corp Earnings per share for the last 12 months (02/21/2024 - 09/19/2026)

Comprehensive metric breakdowns and analytics for Apogee Corp (APGE)

- current quotes and average value forecast:
- company stock exchange capitalization indicators:
Basic company analysis:apogeetherapeutics.com (APGE)
Mass-produced product of Apogee Pharma

For Apogee Therapeutics (APGE), whose model is based on high-risk clinical trials and capital burn, this indicator reflects the actual profit per share over a rolling year. By analyzing the trend of annual net income per share, an investor sees a smoothed dynamic of business efficiency, where any downward momentum signals a critical increase in costs or operating losses.